Guidelines for dyspepsia treatment in Japan

Clinical Therapeutics

Volumn 20, Issue SUPPL. D, 1998, Pages

  Matsueda, Kei ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Dyspepsia; Guidelines; Helicobacter pylori; Japan

Indexed keywords

CIMETIDINE; CISAPRIDE; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ANEMIA; CLINICAL PROTOCOL; DYSPEPSIA; DYSPHAGIA; HELICOBACTER PYLORI; HUMAN; JAPAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; REVIEW; RISK FACTOR; STOMACH CANCER; TREATMENT PLANNING; WEIGHT REDUCTION;

EID: 0032465881     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(98)70002-5     Document Type: Article

References (15)

1. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ. 1989;298:30-32.
2. Bernersen B, Johnsen R, Bostad L, et al. Is Helicobacter pylori the cause of dyspepsia? BMJ. 1992;304:1276-1279.
3. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65-69.
4. The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection: The Maastricht consensus report. Gut. 1997;41:8-13.
5. Whitaker MJ, Brun J, Carelli F, on behalf of the International Gastro Primary Care Group. Controversy and consensus in the management of upper gastrointestinal disease in primary care. Int J Clin Pract. 1997;51:239-243.
6. Heading RC, Wager E, Tooley PJ. Reliability of symptom assessment in dyspepsia. Eur J Gastroenterol Hepatol. 1997;9:779-781.
7. American Gastroenterological Association. American Gastroenterological Association medical position statement: Evaluation of dyspepsia. Gastroenterology. 1998;114:579-581.
8. Steele GH. Cost-effective management of dyspepsia and gastroesophageal reflux disease. Prim Care. 1996;23:561-576.
9. Sonnenberg A. Economic analysis of dyspepsia. Eur J Gastroenterol Hepatol. 1997;9:323-326.
10. Miwa T, Hongo M, Matsueda K. Current concepts of dyspepsia. Report of a Luncheon Seminar to the 39th Congress of the Japanese Gastroenterology Society. Nikkei Med. 1998;January:40-13.
11. Barnes J. National guidelines on dyspepsia. Practitioner. 1998;241:39-41.
12. Reynolds JC. Individualized acute treatment strategies for gastroesophageal reflux disease. Scand J Gastroenterol Suppl. 1995;213:17-24.
13. Hongo M. The concept of NUD: Focus on gastrointestinal motility. Aspects of the efficacy of gastric emptying and electromyography. Ther Res. 1992;13:2599-2603.
14. Miyoshi M. The incidence of dyspepsia, its classification and the effects of cisapride on dyspeptic symptoms. Progr Med. 1993;13:1612-1626.
15. Halter F, Miazza B, Brignoli R. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study. Scand J Gastroenterol. 1994;29:618-623.